Eye Health News

Lutemax 2020 featured in R.B.I. Vision Performance

r-b-i-vision-performance-reg-expiration-date-3-31-2015-5The results of the first
Improved therapy for retinoblastoma patients Reading Lutemax 2020 featured in R.B.I. Vision Performance 2 minutes Next Diabetes risk doubled with 2 sweet drinks daily
The results of the first LAMA (Lutein, Vision and Mental Acuity) study showed that the combination of three macular carotenoids¬†- lutein, zeaxanthin, and mesozeaxanthin - may increase the macular pigment ocular density (MPOD) even faster than previous studies had demonstrated. This study showed that in just a period of eight weeks, the MPOD of study participants increased greatly. Twenty-eight patients participated in the study and they were either given a placebo, or one of three dose levels of Lutemax 2020. The three dose levels all had ratios of lutein to zeaxanthin isomers that were almost identical. While all three Lutemax 2020 dose levels had increased the MPOD levels significantly after 12 weeks, the dosage levels that had 10 mg and 20 mg of lutein saw notable increases to MPOD after just 8 weeks. Dr. Paul Krawitz's R.B.I. Vision Performance has harnessed the power of Lutemax 2020. R.B.I. Vision Performance is formulated to accelerate your retinal transmission speed, heighten contrast and shield your eyes from glare. R.B.I Vision Performance is made with the highest attention to quality with all natural ingredients.*  

USA Only, Spend $50, get free shipping

Free shipping is currently available for orders within the United States only.